Researchers found that in primary care patients with posttraumatic stress disorder, both written exposure therapy and selective serotonin reuptake inhibitors led to meaningful improvement. For selective serotonin reuptake inhibitor nonresponders, switching to venlafaxine produced greater symptom reduction than adding therapy, supporting its use as a second-line option.

Source: JAMA Psychiatry